In a recent GlobalData survey, “The State of the Biopharmaceutical Industry 2024 (mid-year update)”, 73% of surveyed healthcare industry professionals felt optimistic or very optimistic about the industry’s growth during the next 12 months, up by 13% from the data received six months ago (60%) and up a further 13% from 2023 (47%), but still below the levels seen in 2022 (81%).